This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Philippe Yves-Remy Simon, Vita Api. Active years: 2021.
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2021
Title: Anouk Siri: Innovator in Cancer and Neurodegenerative Disorder Treatments
Introduction
Anouk Siri is a prominent inventor based in Marseille, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for cancer and neurodegenerative disorders. Her innovative work has led to the creation of a patent that showcases her expertise and dedication to improving healthcare.
Latest Patents
Anouk Siri holds a patent for "Proteasome inhibiting β-lactam prodrugs useful for the treatment of cancer and neurodegenerative disorders." This invention relates to proteasome inhibiting β-lactam compounds that are beneficial in treating these serious health conditions. The patent also includes pharmaceutical compositions and extended release formulations of these compounds, highlighting their medical uses in combating cancer and neurodegenerative disorders.
Career Highlights
Throughout her career, Anouk has worked with various companies, including Philippe Yves-Rémy Simon and Vita Api. Her experience in these organizations has allowed her to collaborate with other professionals and enhance her knowledge in the pharmaceutical field.
Collaborations
Anouk has collaborated with notable individuals such as Philippe Yves-Rémy Simon and Henri Oreal. These partnerships have contributed to her success and the advancement of her innovative projects.
Conclusion
Anouk Siri is a remarkable inventor whose work in developing treatments for cancer and neurodegenerative disorders has the potential to make a significant impact on healthcare. Her dedication to innovation and collaboration continues to drive her success in the pharmaceutical industry.